FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Gemcitabine Hydrochloride Injection
Status: Discontinuation
»Therapeutic Categories: Oncology

Expand all

Mylan Institutional (New 12/16/2019)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
1 g, single dose vial (NDC 67457-462-01) 12/16/2019 Expected Discontinuation March/April 2020

Mylan Pharmaceuticals Inc., a Viatris Company (New 06/26/2020)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
200 mg, single dose vial (NDC 67457-464-20) 06/26/2020 Expected discontinuation December 2020

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English